age
process
lead
signific
declin
physiolog
morpholog
function
human
bodi
make
elderli
patient
suscept
infect
relationship
older
age
infect
easili
evalu
sinc
limit
data
exist
concern
specif
condit
eg
sever
commun
acquir
pneumonia
nosocomi
bacteremia
subpopul
postop
patient
within
elderli
date
effort
small
singl
center
cohort
tri
studi
elderli
patient
togeth
specif
characterist
risk
factor
associ
certain
infect
chronic
obstruct
pulmonari
diseas
copd
complic
frequent
exacerb
call
acut
exacerb
chronic
obstruct
pulmonari
diseas
aecopd
associ
high
morbid
increas
use
health
resourc
aggrav
health
statu
patient
main
risk
factor
aecopd
develop
consid
infect
respiratori
system
caus
viru
bacteria
respons
approxim
event
signific
viral
infect
recogn
last
decad
develop
clinic
applic
newer
molecular
techniqu
abl
detect
viral
speci
easili
detect
serolog
viral
cultur
human
metapneumoviru
recent
evalu
epidemiolog
viral
infect
cohort
patient
aecopd
show
viral
infect
strongli
associ
aecopd
develop
independ
stage
copd
infect
viral
bacteri
pathogen
common
patient
cohort
high
percentag
elderli
patient
aecopd
due
viral
infect
reason
conduct
present
studi
aim
investig
possibl
differ
among
elderli
nonelderli
patient
aecopd
viral
origin
previous
conduct
year
prospect
studi
focus
infecti
etiolog
aecopd
briefli
cohort
studi
patient
age
year
visit
emerg
depart
tertiari
care
hospit
admit
inpati
facil
copd
exacerb
accord
gold
criteria
without
hospit
last
three
month
use
antibiot
last
day
without
diagnosi
bronchial
asthma
includ
patient
report
histori
infect
last
month
receiv
system
corticosteroid
therapi
studi
period
last
januari
june
studi
taken
approv
ethic
committe
hospit
patient
recruit
studi
sign
written
inform
consent
absenc
clear
definit
elderli
patient
medic
literatur
age
cut
chosen
studi
base
world
health
organ
definit
elderli
accord
statement
develop
world
countri
accept
chronolog
age
year
definit
elderli
older
person
definit
consid
somewhat
arbitrari
howev
usual
associ
age
person
begin
receiv
pension
benefit
current
unit
nation
standard
numer
criterion
un
agre
cutoff
year
order
refer
older
popul
follow
paramet
record
admiss
age
sex
stage
copd
accord
gold
criteria
smoke
habit
alcohol
addict
use
oxygen
influenza
vaccin
comorbid
confirm
medic
record
current
medic
well
sign
symptom
respiratori
tract
infect
patient
underw
routin
blood
examin
includ
c
reactiv
protein
chest
radiograph
sputum
cultur
common
bacteria
patient
assign
copd
stage
base
gold
criteria
accord
recent
avail
spirometr
valu
last
three
month
patient
mild
copd
stage
predict
valu
patient
moder
copd
stage
ii
predict
valu
patient
sever
copd
stage
iii
predict
valu
patient
sever
copd
stage
iv
predict
valu
valu
predict
plu
chronic
respiratori
failur
underw
spirometri
discharg
hospit
patient
followedup
throughout
recoveri
exacerb
discharg
hospit
follow
first
evalu
initi
treatment
sputum
oropharyng
sampl
gargl
collect
submit
viral
detect
clinic
microarray
techniqu
ie
pneumovir
kit
genomica
spain
method
abl
detect
character
frequent
type
human
virus
respons
respiratori
infect
identifi
small
quantiti
viral
genom
materi
use
sequenc
correspond
highli
preserv
region
within
viral
genom
bind
probe
specif
respiratori
viru
type
virus
analyz
includ
human
respiratori
syncyti
viru
hrsv
type
b
human
metapneumoviru
hmpv
type
b
influenza
viru
type
b
c
rhinoviru
parainfluenza
viru
hpiv
subtyp
b
enteroviru
echoviru
adenoviru
coronaviru
bocaviru
sampl
collect
thin
prep
solut
centrifug
molecular
procedur
perform
accord
manufactur
instruct
brief
viral
dnarna
extract
use
clinic
sampl
mix
lysi
buffer
allow
stand
room
temperatur
minut
isopropanol
ad
centrifug
perform
rpm
min
follow
remov
supernat
precipit
resuspend
ethanol
follow
centrifug
rpm
min
supernat
remov
sampl
left
dri
min
ethanol
residu
left
end
pellet
resuspend
dilut
solut
viral
dnarna
extract
store
amplif
viru
amplif
perform
via
two
rt
revers
transcriptas
multiplex
pcr
reaction
specif
bp
fragment
viral
genom
pcr
employ
follow
thermal
cycler
set
cycl
min
min
follow
cycl
sec
min
min
final
cycl
min
visual
amplifi
product
perform
platform
base
lowdens
microarray
call
array
tube
detect
system
base
precipit
insolubl
product
site
hybrid
product
amplifi
specif
molecular
probe
produc
amplifi
product
label
biotin
pcr
amplif
hybrid
respect
specif
probe
immobil
specif
known
site
incub
streptavidinperoxidas
conjug
conjug
bind
via
streptavidin
biotin
present
amplifi
product
also
bound
specif
probe
presenc
odianisidin
peroxidas
activ
conjug
induc
appear
insolubl
product
precipit
hybrid
site
qualit
variabl
express
count
percentag
quantit
variabl
express
mean
standard
deviat
student
test
independ
sampl
use
perform
comparison
mean
wherea
manwhitney
test
use
case
variabl
meet
criteria
normal
chisquar
fisher
exact
test
use
comparison
proport
p
valu
less
consid
signific
data
analyz
use
statist
softwar
spss
version
spss
chicago
il
total
patient
recruit
studi
sign
inform
consent
meet
inclus
criteria
patient
sampl
suitabl
analysi
obtain
invalid
result
clart
common
caus
amplif
process
may
interf
unknown
substanc
might
inhibit
dna
polymeras
enzym
altogeth
patient
consid
suitabl
analyz
median
age
year
old
patient
year
old
year
old
p
demograph
recruit
patient
shown
tabl
elderli
patient
group
b
show
higher
rate
vaccin
influenza
vs
p
cardiac
failur
vs
p
renal
failur
vs
bacteri
infect
among
recruit
patient
viral
infect
detect
patient
without
howev
statist
differ
group
b
vs
durat
hospit
stay
longer
group
b
day
without
differ
mortal
analyz
separ
patient
viru
isol
found
age
vaccin
rate
influenza
vs
p
use
inhal
steroid
vs
higher
group
b
tabl
detect
virus
order
frequenc
human
respiratori
syncyti
viru
hrsv
subtyp
b
n
influenza
viru
type
b
c
parainfluenza
viru
hpiv
sybtyp
rhinoviru
human
metapneumoviru
hmpv
subtyp
b
coronaviru
adenoviru
enteroviru
echoviru
bocaviru
type
isol
virus
accord
age
shown
fig
tabl
statist
signific
differ
note
two
group
except
infect
patient
group
b
patient
group
also
mix
viral
infect
isol
two
virus
present
frequenc
elderli
nonelderli
group
patient
group
b
vs
patient
group
observ
made
influenza
c
infect
patient
group
b
vs
patient
group
patient
bacteri
infect
patient
infect
bacteri
viral
pathogen
dual
infect
identifi
commonli
isol
bacteria
pseudomona
aeruginosa
haemophilu
influenza
klebsiella
pneumonia
staphylococcu
aureu
acinetobact
baumanii
stenotrophomona
maltophilia
statist
signific
differ
evid
season
pattern
rsv
infect
infect
p
influenza
viru
infect
subtyp
p
respect
tabl
without
howev
statist
differ
elderli
nonelderli
patient
tabl
studi
found
high
frequenc
aecopd
due
viral
infect
elderli
nonelderli
patient
without
differ
two
group
b
frequent
infect
due
human
parainfluenza
viru
hpiv
influenza
elderli
patient
compar
nonelderli
longer
c
lengthier
hospit
stay
elderli
patient
recent
publish
studi
evalu
epidemiolog
viral
infect
patient
aecopd
high
rate
viral
infect
detect
accord
previous
publish
report
studi
compar
frequenc
viral
infect
among
elderli
nonelderli
patient
differ
detect
possibl
explan
could
fact
copd
chronic
system
inflammatori
syndrom
affect
immun
respons
independ
age
make
patient
prone
infect
elderli
larg
even
grow
popul
proport
age
gener
hospit
popul
group
patient
character
declin
immunolog
respons
infect
princip
due
function
insuffici
monocyt
macrophag
result
inadequ
phagocytosi
lack
antigen
present
cell
dendrit
cell
naiv
tcell
due
thymu
gland
involut
loss
memori
capac
matur
tcell
exhibit
poor
andor
alter
cytokin
product
decreas
number
circul
bcell
result
weaker
respons
antigen
challeng
immunoglobulin
product
elderli
usual
higher
rate
vaccin
influenza
primari
care
physician
nonelderli
although
risk
howev
differ
detect
either
influenza
viru
virus
detect
rate
could
explain
fact
immun
respons
vaccin
declin
substanti
age
thu
elderli
impair
humor
cell
mediat
immun
respons
influenza
vaccin
compar
younger
adult
also
point
need
better
prevent
measur
respiratori
virus
popul
strong
associ
comorbid
number
type
older
age
well
known
copd
patient
usual
increas
number
comorbit
cardiovascular
diseas
respiratori
tract
diseas
metabol
diseas
haematolog
diseas
coagulopathi
musculoskelet
diseas
gastrointestin
diseas
renal
diseas
psychiatr
diseas
neoplasia
known
copd
comorbidom
consid
copd
relat
eg
respiratori
failur
pulmonari
heart
diseas
cachexia
copdnon
relat
eg
obes
diabet
mellitu
arteri
hypertens
patient
cardiac
renal
failur
diabet
mellitu
frequent
detect
comorbit
increas
number
could
explain
orient
center
special
site
cardiorespiratori
diseas
greec
infect
due
bacteri
pathogen
common
elderli
subject
hospit
stay
lengthier
patient
need
time
recov
complex
copd
either
system
oxid
stress
syndrom
inflammatori
process
combin
weaker
immun
respons
result
inflammatori
process
frequent
colon
bacteria
lead
bacteri
infect
coinfect
viralbacteri
main
statement
recent
publish
studi
longer
hospit
stay
aecopd
patient
coexist
candidiasi
anemia
psycholog
disord
atrial
fibril
congest
heart
diseas
asthma
respiratori
failur
cachexia
detect
find
differ
mortal
elderli
aecopd
patient
viral
infect
compar
nonelderli
although
mortal
higher
copd
patient
lung
cancer
pulmonari
heart
diseas
heart
failur
atrial
fibril
obstruct
sleep
apnea
obes
osteoporosi
asthma
isol
type
virus
two
group
present
differ
tabl
except
detect
human
parainfluenza
virus
hpiv
consid
one
common
caus
lower
respiratori
tract
infect
children
difficult
understand
biolog
signific
cohort
one
possibl
explan
could
occurr
clonal
hpiv
outbreak
studi
period
analyz
season
pattern
viral
infect
statist
differ
note
although
well
known
copd
patient
present
commonli
exacerb
cold
season
winterautumn
viral
infect
higher
preval
period
associ
longer
recoveri
period
longer
hous
stay
increas
likelihood
hospit
admiss
also
despit
import
role
viral
infect
studi
difficult
examin
true
pathogen
role
sinc
virus
increas
evid
could
colon
respiratori
tract
colon
may
act
modul
local
immun
respons
subsequ
bacteri
upper
tract
infect
alreadi
suscept
patient
exact
interact
bacteri
viral
colon
issu
debat
studi
limit
first
quantit
pcr
techniqu
perform
order
test
modif
viral
load
specif
viru
could
indic
activ
viru
previous
colon
patient
exacerb
second
patient
aecopd
frequent
receiv
home
care
moder
mild
episod
reason
could
miss
fraction
similar
episod
occur
commun
third
low
yield
sputum
cultur
regard
confirm
bacteri
infect
could
miss
bacteri
pathogen
inhabit
infect
respiratori
tract
forth
evid
convinc
explan
high
detect
rsv
conclus
signific
percentag
elderli
peopl
aecopd
viral
pathogen
detect
upper
respiratori
tract
human
parainfluenza
virus
mix
viral
infect
common
elderli
subject
exact
role
differ
viral
speci
matter
research
